Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Current Assets (2018 - 2025)

Neurogene's Current Assets history spans 6 years, with the latest figure at $271.8 million for Q4 2025.

  • For Q4 2025, Current Assets fell 13.98% year-over-year to $271.8 million; the TTM value through Dec 2025 reached $271.8 million, down 13.98%, while the annual FY2025 figure was $271.8 million, 13.98% down from the prior year.
  • Current Assets reached $271.8 million in Q4 2025 per NGNE's latest filing, roughly flat from $270.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $315.9 million in Q4 2024 to a low of $79.9 million in Q3 2023.
  • Average Current Assets over 3 years is $196.7 million, with a median of $187.2 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 103.35% in 2024, then decreased 13.98% in 2025.
  • A 3-year view of Current Assets shows it stood at $200.3 million in 2023, then surged by 57.69% to $315.9 million in 2024, then decreased by 13.98% to $271.8 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Current Assets are $271.8 million (Q4 2025), $270.5 million (Q3 2025), and $279.0 million (Q2 2025).